CTI-Medidata partner to adopt Remote Source Review in clinical trials
Category: #health  By Saipriya Iyer  Date: 2020-07-10
  • sharesocial_share_icon
  • Twitter
  • Facebook
  • LinkedIn

CTI-Medidata partner to adopt Remote Source Review in clinical trials

CTI Clinical Trial and Consulting Services will reportedly adopt Remote Source Review of Medidata. Medidata is the end-to-end solutions provider to support the clinical trials. This contract research organization will use the service to upgrade the remote monitoring & document review process for various global studies, including projects related to COVID-19.

The coronavirus pandemic has increased the burden on medical professionals in developing drugs or vaccines due to travel restrictions and limited access to the clinical research sites. Medidata has been supporting various researchers in advancing the clinical trials during the unprecedented times. The company significantly aligns its imaging workflow solution to remotely, securely, and rapidly assist researchers in source document review and critical document acquisition.

According to Medidata’s co-founder and co-CEO, Glen de Vries, the company has strategized upon developing & deploying the technology that is necessary to ensure high discoveries. It is excited to partner with CTI to advance the clinical trials to treat various patients suffering from infectious diseases and cancer. The support services offered by the company will considerably lead to medical progress and help tackle the pandemic during this crucial period.

Remote Source Review of Medidata is a quick-to-implement technology that is built on its Rave Imaging system. The solution has been deployed already in over 15,000 clinical sites. It is valuable for use especially when clinical studies have critical timelines. It also helps the researchers when there are no secured options to de-identify, review, collect, and redact PII (Personally Identifiable Information). Additionally, it improves the CRA (clinical research associate) productivity by lowering travel costs and time.

As per the statement made by Timothy Schroeder, CTI’s founder and CEO, standardizing trials with Medidata technology and improving the remote monitoring capabilities are highly critical during the ongoing coronavirus pandemic. The company is targeting to reduce the disruptions to research, accelerate the virtual trial management, ensure data collection & integrity, and remotely manage source documents.

Source credit:

https://www.businesswire.com/news/home/20200708005231/en/Medidata-Partners-CTI-Remote-Source-Review-Clinical



About Author

Saipriya Iyer

Email: [email protected]   linkdin twitter

Saipriya Iyer

Saipriya Iyer develops content for Market Size Forecasters, Algosonline, and myriad other platforms. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her bel...

More News By Saipriya Iyer

 Tabletop Tape Dispensers  market valuation to surge at healthy CAGR through 2026

Tabletop Tape Dispensers market valuation to surge at healthy CAGR through 2026

By Saipriya Iyer

A comprehensive research study on Tabletop Tape Dispensers market added by Market Study Report provides insights into the market size and growth trends of this industry over the forecast timeline. The study evaluates key aspects of Tabletop Tape D...

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

APAC, Europe, America region to generate massive revenues for General Well-Being Dietary Supplements market by 2026

By Saipriya Iyer

MarketStudyReport.com presents latest report on global General Well-Being Dietary Supplements Market, which evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The re...

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

Eugenia Jambolana Extract Market to Increase Exponentially During 2027

By Saipriya Iyer

The report Eugenia Jambolana Extract market provides high-quality information regarding the major market trends, product types and their application scope, competitive landscape, and impact of COVID-19 outbreak.

.

Request a...